| scholarly article | Q13442814 |
| P50 | author | Paul J. Brindley | Q51247593 |
| F Gartner | Q59089610 | ||
| P2093 | author name string | Nuno Vale | |
| José M Correia da Costa | |||
| Maria João Gouveia | |||
| P2860 | cites work | Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis | Q44012685 |
| Preventive effect of artemether in experimental animals infected with Schistosoma mansoni | Q44101460 | ||
| Artemether as adjuvant therapy to praziquantel in murine Egyptian schistosomiasis mansoni | Q44311141 | ||
| Antioxidant and schistosomicidal effect of Allium sativum and Allium cepa against Schistosoma mansoni different stages. | Q44405662 | ||
| Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection | Q44519846 | ||
| Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine | Q44540218 | ||
| Artesunate effect on schistosome thioredoxin glutathione reductase and cytochrome c peroxidase as new molecular targets in schistosoma mansoni-infected mice. | Q44556632 | ||
| Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel | Q44567644 | ||
| First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection | Q44917077 | ||
| Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. | Q45181572 | ||
| Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni | Q46106188 | ||
| The effect of antioxidant properties of aqueous garlic extract and Nigella sativa as anti-schistosomiasis agents in mice. | Q46125970 | ||
| The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand | Q46247381 | ||
| Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria | Q46329536 | ||
| Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice | Q46400668 | ||
| Praziquantel binds Schistosoma mansoni adult worm actin. | Q46531951 | ||
| Sativa seeds against Schistosoma mansoni different stages | Q46602116 | ||
| Schistosoma mansoni: melatonin enhances efficacy of cercarial and soluble worm antigens in the induction of protective immunity against infection in the hamster. | Q46709287 | ||
| Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity | Q46915902 | ||
| Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni | Q46921243 | ||
| Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice. | Q46973118 | ||
| Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum | Q47956006 | ||
| Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment | Q21090121 | ||
| Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis | Q21560762 | ||
| A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistosomiasis japonica in China | Q24646717 | ||
| Thioredoxin glutathione reductase-dependent redox networks in platyhelminth parasites | Q26829491 | ||
| Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel | Q27304398 | ||
| Serotonin signaling in Schistosoma mansoni: a serotonin-activated G protein-coupled receptor controls parasite movement | Q27331388 | ||
| In vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosine | Q27339703 | ||
| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
| Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites | Q27680669 | ||
| Schistosomiasis | Q28215200 | ||
| Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target | Q28469234 | ||
| Mefloquine--an aminoalcohol with promising antischistosomal properties in mice | Q28474353 | ||
| Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children | Q28476262 | ||
| New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum | Q28478257 | ||
| Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni | Q28480620 | ||
| Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis | Q28539314 | ||
| Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial | Q28540831 | ||
| The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response | Q28541466 | ||
| Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial | Q28547483 | ||
| Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms | Q28553673 | ||
| Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | Q29547716 | ||
| Prevention and control of schistosomiasis and soil-transmitted helminthiasis | Q29619082 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| Schistosomiasis therapeutics: whats in the pipeline? | Q50966400 | ||
| Immunological indicators of morbidity in human schistosomiasis mansoni: role of vascular endothelial growth factor and anti-soluble egg antigen IgG4 in disease progression. | Q51036241 | ||
| Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. | Q52266862 | ||
| Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice. | Q52672813 | ||
| Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates. | Q53605480 | ||
| Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren. | Q53888452 | ||
| Praziquantel: is there real resistance and are there alternatives? | Q53973326 | ||
| Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice. | Q54052490 | ||
| A comparative study of the reproductive system of mature, immature and "unisexual" female Schistosoma mansoni. | Q54162318 | ||
| The anti-schistosomal drug praziquantel is an adenosine antagonist | Q58070149 | ||
| A New Series of 2-Aminomethyltetrahydroquinoline Derivatives displaying Schistosomicidal Activity in Rodents and Primates | Q59057898 | ||
| Schistosoma mansoni: cloning the gene encoding glutathione peroxidase | Q61638099 | ||
| Efficacy of combination therapy with tubercidin and nitrobenzylthioinosine 5'-monophosphate against chronic and advanced stages of schistosomiasis | Q67984153 | ||
| Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite | Q67984511 | ||
| Antischistosomal action of mevinolin: evidence that 3-hydroxy-methylglutaryl-coenzyme a reductase activity in Schistosoma mansoni is vital for parasite survival | Q68368986 | ||
| Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors | Q69464117 | ||
| Combination therapy of Schistosoma japonicum by tubercidin and nitrobenzylthioinosine 5'-monophosphate | Q69971848 | ||
| The treatment of experimental schistosomiasis with a combination of oxamniquine and praziquantel | Q71221403 | ||
| Experimental murine schistosomiasis: reduced hepatic morbidity after pre- and/or post-infection treatment with ibuprofen or diclofenac sodium | Q71576601 | ||
| What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? | Q73108356 | ||
| Intranasal administration of Schistosoma mansoni adult worm antigen in combination with cholera toxin induces a Th2 cell response | Q73335588 | ||
| Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits | Q73576307 | ||
| Combination antiretroviral therapy for HIV infection | Q74685124 | ||
| Schistosome resistance to praziquantel | Q80098643 | ||
| Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni | Q80161238 | ||
| Is actin the praziquantel receptor? | Q80584028 | ||
| Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants | Q83131030 | ||
| Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection | Q84556558 | ||
| Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis | Q84700726 | ||
| Comparative in vivo antioxidant levels in Schistosoma mansoni infected mice treated with praziquantel or the essential oil of Melaleuca armillaris leaves | Q86663950 | ||
| The action of UK 3883, a novel 2-aminomethyltetra-hydroquinoline derivative, against mature schistosomes in rodents and primates | Q93824345 | ||
| Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2015 | Q95383221 | ||
| Schistosomiasis: number of people treated worldwide in 2013 | Q95602733 | ||
| Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice | Q30485364 | ||
| Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report | Q31158829 | ||
| Parasites and poverty: the case of schistosomiasis | Q33615662 | ||
| The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases | Q33945536 | ||
| The schistosome enzyme that activates oxamniquine has the characteristics of a sulfotransferase | Q34002522 | ||
| Fixed dose combination of arterolane and piperaquine: a newer prospect in antimalarial therapy | Q34162314 | ||
| Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome | Q34287092 | ||
| Human schistosomiasis | Q34413522 | ||
| The potential of artemether for the control of schistosomiasis | Q34455017 | ||
| Break Out: urogenital schistosomiasis and Schistosoma haematobium infection in the post-genomic era. | Q34654134 | ||
| The immunobiology of schistosomiasis | Q34718128 | ||
| Schistosome and liver fluke derived catechol-estrogens and helminth associated cancers | Q34763466 | ||
| Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials | Q34939414 | ||
| Human schistosomiasis: clinical perspective: review | Q34951716 | ||
| Synergy of concurrent low dose oxamniquine and praziquantel in schistosomiasis | Q34995195 | ||
| Drugs for the control of parasitic diseases: current status and development in schistosomiasis | Q35569078 | ||
| Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells | Q35586128 | ||
| Artemisinin-based combinations | Q36300935 | ||
| Why does infection with some helminths cause cancer? | Q36310498 | ||
| Artemisinins for schistosomiasis and beyond. | Q36747308 | ||
| Chemotherapy of schistosomiasis: present and future | Q36891317 | ||
| Selection of a trioxaquine as an antimalarial drug candidate | Q36965586 | ||
| MCR synthesis of praziquantel derivatives | Q37017439 | ||
| Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection | Q37199411 | ||
| Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
| Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges | Q37405246 | ||
| Combination therapy of schistosomiasis by tubercidin and nitrobenzylthioinosine 5'-monophosphate | Q37549813 | ||
| Schistosoma genomics: new perspectives on schistosome biology and host-parasite interaction. | Q37561082 | ||
| Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application | Q37700067 | ||
| Susceptibility or resistance of praziquantel in human schistosomiasis: a review | Q38050973 | ||
| New vaccines for neglected parasitic diseases and dengue | Q38098308 | ||
| Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery | Q38116989 | ||
| The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer). | Q38175909 | ||
| Schistosomiasis control: praziquantel forever? | Q38222456 | ||
| The chronic enteropathogenic disease schistosomiasis | Q38253817 | ||
| Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial | Q38374795 | ||
| Malaria medicines: a glass half full? | Q38497838 | ||
| Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study | Q38915536 | ||
| Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni | Q38990123 | ||
| IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease | Q38992502 | ||
| Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni | Q39021863 | ||
| Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer. | Q39030300 | ||
| Schistosomiasis elimination: lessons from the past guide the future | Q39031600 | ||
| Schistosoma haematobium infections acquired in Corsica, France, August 2013. | Q39074543 | ||
| Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro | Q39126577 | ||
| Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance. | Q39164325 | ||
| The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer. | Q39201937 | ||
| Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni | Q39237134 | ||
| Advancing a vaccine to prevent human schistosomiasis | Q39246394 | ||
| Schistosoma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. | Q39318216 | ||
| Naphthoquine phosphate and its combination with artemisinine | Q39385050 | ||
| Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals | Q39544935 | ||
| A review of clinical experience with oxamniquine | Q39602046 | ||
| Praziquantel: mechanisms of anti-schistosomal activity | Q39842409 | ||
| Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis. | Q39879484 | ||
| Purine metabolism in the schistosomes: potential targets for chemotherapy | Q40208606 | ||
| In vivo and in vitro activity of oil extract of garlic (Allium sativum Linnaeus) against Schistosoma japonicum cercariae | Q40284457 | ||
| Resveratrol ameliorates oxidative stress and organ dysfunction in Schistosoma mansoni infected mice | Q40342929 | ||
| Accessory cell signals regulate Th-cell responses: from basic immunology to a model of helminthic disease | Q40587479 | ||
| Immunomodulatory effect of garlic oil extract on Schistosoma mansoni infected mice. | Q40856555 | ||
| Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni | Q41587975 | ||
| Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline | Q41917949 | ||
| Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of Schistosoma mansoni | Q42080804 | ||
| Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis | Q42239154 | ||
| Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. | Q42745282 | ||
| In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms | Q43245982 | ||
| Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum | Q43268214 | ||
| Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini | Q43276729 | ||
| Eosinophils from schistosome-induced hepatic granulomas produce superoxide and hydroxyl radical | Q43515480 | ||
| The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice | Q43823575 | ||
| Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice | Q43857691 | ||
| In vitro and in vivo effects of hesperidin treatment on adult worms of Schistosoma mansoni | Q43981019 | ||
| Efficacy of a new Hoffmann-La Roche compound (Ro 15-5458) against Schistosoma mansoni (Gezira strain, Sudan) in vervet monkeys (Cercopithecus aethiops). | Q43988350 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | schistosomiasis | Q221159 |
| P577 | publication date | 2018-02-05 | |
| P1433 | published in | Pharmaceuticals | Q15750667 |
| P1476 | title | Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules | |
| P478 | volume | 11 |
| Q58543612 | An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni |
| Q92470282 | Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model |
| Q64245750 | Combination Anthelmintic/Antioxidant Activity Against |
| Q89920010 | Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs |
| Q55459515 | Innovation in neglected tropical disease drug discovery and development. |
| Q90859559 | Schistosomiasis |
| Q99550129 | Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni |
Search more.